← back to search

Aaron R. Thorner

Dana-Farber Cancer Institute · US
🔎 Find collaborators in Pulmonary and Respiratory Medicine · Cancer Research →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Cancer Genomics and Diagnostics, Sarcoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, and Renal cell carcinoma treatment.
h-index
50
citations
12,922
works
280
NIH funding
primary concept
email

Recent publications

Author Correction: A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features
Nature Medicine 2025cited by 0position: middledoi
A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features
Nature Medicine 2024cited by 70position: middledoi
Abstract PD6-03: Spatio-molecular dissection of the breast cancer metastatic microenvironment
Cancer Research 2022cited by 1position: middledoi
Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes
Cancers 2021cited by 22position: middledoi
Cas9 activates the p53 pathway and selects for p53-inactivating mutations
Nature Genetics 2020cited by 283position: middledoi
Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations
Cancer Discovery 2020cited by 146position: middledoi
Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations
Nature Genetics 2020cited by 13position: middledoi
Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion
Blood Advances 2019cited by 162position: middledoi
Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade
Blood 2019cited by 104position: middledoi
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Nature Medicine 2018cited by 1,952position: middledoi
Genetic and transcriptional evolution alters cancer cell line drug response
Nature 2018cited by 935position: middledoi
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer
Genetics in Medicine 2018cited by 216position: middledoi
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group
British Journal of Cancer 2018cited by 136position: middledoi
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
Nature Communications 2018cited by 113position: middledoi
Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia
Leukemia 2018cited by 55position: middledoi
Author Correction: Molecular subtypes of diffuse large B celllymphoma are associated with distinct pathogenic mechanisms and outcomes
Nature Medicine 2018cited by 32position: middledoi
Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma
JAMA Oncology 2017cited by 269position: middledoi
Genomic landscape of high-grade meningiomas
npj Genomic Medicine 2017cited by 208position: middledoi
Erratum: Genomic landscape of high-grade meningiomas
npj Genomic Medicine 2017cited by 27position: middledoi
Abstract 562: Oncovirus detection and integration analysis from human tumor samples using targeted massively parallel sequencing
Cancer Research 2017cited by 0position: middledoi
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Cancer Cell 2016cited by 303position: middledoi
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease
Blood 2016cited by 84position: middledoi
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Cancer Discovery 2015cited by 1,128position: middledoi
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Blood 2015cited by 597position: middledoi
The Genomic Landscape of Pediatric Ewing Sarcoma
Cancer Discovery 2014cited by 583position: middledoi
Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
Nature Genetics 2014cited by 507position: middledoi
High-Throughput Tyrosine Kinase Activity Profiling Identifies FAK as a Candidate Therapeutic Target in Ewing Sarcoma
Cancer Research 2013cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2017–2020)Paul Van Hummelen · Natera (United States)4 papers (2016–2017)Matthew D. Ducar · Dana-Farber Cancer Institute4 papers (2016–2019)Rameen Beroukhim · Broad Institute4 papers (2017–2020)Scott J. Rodig · Massachusetts Institute of Technology3 papers (2016–2019)Bjoern Chapuy · Humboldt-Universität zu Berlin3 papers (2016–2019) · 3 papers (2017–2018)Margaret A. Shipp · Harvard University3 papers (2016–2019)John G. Doench · Broad Institute2 papers (2020–2020)Matthew Meyerson · Harvard University2 papers (2017–2020)Mai Abdusamad · APLA Health2 papers (2020–2020)Noah F. Greenwald · Stanford University2 papers (2017–2017)Julian M. Hess · Broad Institute2 papers (2020–2020)Ekaterina Esaulova · ITMO University2 papers (2017–2017)Malak Abedalthagafi · Tufts University2 papers (2017–2017)Verónica Rendo · Science for Life Laboratory2 papers (2020–2020) · 2 papers (2017–2017)Gavin P. Dunn · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2017–2017)Naomi Currimjee · Dana-Farber Cancer Institute2 papers (2020–2020)Steven E. Schumacher · NorthShore University HealthSystem2 papers (2017–2017)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pulmonary and Respiratory Medicine · Cancer Research →